![Evonik](https://www.pharmacompass.com/image/flap/evonik-corp-ad-w19-desktop-headergif-85675.gif)
![Evonik](https://www.pharmacompass.com/image/flap/evonik-corp-ad-w19-mobile-headergif-68839.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
Details:
Generic Foscarnet Sodium Injection is the bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Foscavir® Injection, 24 mg/mL, of Clinigen Healthcare Limited.
Lead Product(s): Foscarnet Sodium
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 22, 2021